4.8 Article

The EuroFlow PID Orientation Tube for Flow Cytometric Diagnostic Screening of Primary Immunodeficiencies of the Lymphoid System

Journal

FRONTIERS IN IMMUNOLOGY
Volume 10, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2019.00246

Keywords

flow cytometric immunophenotyping; primary immunodeficiencies; automated gating strategy; standardization; EuroFlow

Categories

Funding

  1. EuroFlow Consortium
  2. Australian National Health and Medical Research Council [GNT1117687]
  3. Ministry of Health [15-28541A]
  4. Ministry of Education, Youth and Sports [LO1604]
  5. Grant Agency of the Czech Republic [GBP302/12/G101]
  6. Junta de Castilla y Leon (Fondo Social Europeo, Valladolid, Spain) [ORDEN EDU/346/2013]
  7. CIBER/ONC, Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, - Madrid, Spain [CB16/12/00400]
  8. FONDOS FEDER [CB16/12/00400]
  9. Fondo de Investigacion Sanitaria of Instituto de Salud Carlos III, Madrid, Spain [FIS PI12/00905-FEDER]
  10. Fundacion Mutua Madrilena, Madrid, Spain [AP119882013]

Ask authors/readers for more resources

In the rapidly evolving field of primary immunodeficiencies (PID), the EuroFlow consortium decided to develop a PID orientation and screening tube that facilitates fast, standardized, and validated immunophenotypic diagnosis of lymphoid PID, and allows full exchange of data between centers. Our aim was to develop a tool that would be universal for all lymphoid PIDs and offer high sensitivity to identify a lymphoid PID (without a need for specificity to diagnose particular PID) and to guide and prioritize further diagnostic modalities and clinical management. The tube composition has been defined in a stepwise manner through several cycles of design-testing-evaluation-redesign in a multicenter setting. Equally important appeared to be the standardized pre-analytical procedures (sample preparation and instrument setup), analytical procedures (immunostaining and data acquisition), the software analysis (a multidimensional view based on a reference database in Infinicyt software), and data interpretation. This standardized EuroFlow concept has been tested on 250 healthy controls and 99 PID patients with defined genetic defects. In addition, an application of new EuroFlow software tools with multidimensional pattern recognition was designed with inclusion of maturation pathways in multidimensional patterns (APS plots). The major advantage of the EuroFlow approach is that data can be fully exchanged between different laboratories in any country of the world, which is especially of interest for the PID field, with generally low numbers of cases per center.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available